Editor's Pick

Stocks discussed: California Resources Corp (NYSE:CRC), Gold Resource Corporation (NYSEMKT:GORO), Intrepid Potash, Inc. (NYSE:IPI). Stocks mentioned: Barrick Gold Corporation (USA) (NYSE:ABX), Franco Nevada Corp (NYSE:FNV) California Resources California Resources Corp (NYSE:CRC) closed out its session on June 3, 2016 at a little under $15 a share. At time of writing, the company...

Companies discussed: Biogen Inc (NASDAQ:BIIB), Sarepta Therapeutics Inc (NASDAQ:SRPT), Catabasis Pharmaceuticals Inc (NASDAQ:CATB) Biogen First up, Biogen Inc (NASDAQ:BIIB). Biogen is a little larger than our normal focus range market capitalization here at Small Cap Exclusive, but it’s making waves in the biotech space on the back of some trial data,...

Midcoast Energy Partners LP (NYSE:MEP) are trading at $9.40, up 4.44% on Tuesday, and around the upper half of its 52-week range between $3.76 to $13.57. The company's stock has shown strong bullish momentum in May, thanks to upbeat earnings and analysts' upgrades. Midcoast Energy Partners is a limited partnership...

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares rose to $19.67 as of the market close on Tuesday but retreated by 0.10% to $19.65 in after hours trading. The company recently got a request from the FDA for dystrophin data before making a decision on the eteplirsen NDA. A few months back, Sarpeta Therapeutics shares...

Companies discussed: GlycoMimetics Inc (NASDAQ:GLYC), Cara Therapeutics Inc (NASDAQ:CARA), Advaxis, Inc (NASDAQ:ADXS) GlycoMimetics First up, GlycoMimetics Inc (NASDAQ:GLYC). GlycoMimetics just kicked off a phase 2 trial in patient with relapsed/refractory acute myeloid leukemia. The trial is the second part of a phase 1/2 in its lead oncology candidate, GMI1271, investigating the drug in combination...